Abcuro
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
$66MSeries D
Role not disclosedP
Pontifax
Activity from announced rounds
Activity in this selectionthe-family-fund-075bdd15
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $66M 1 disclosed · full round size, not this investor’s share